Optimization and Development of a Scalable Palladium-Catalyzed C-H Activation Process for the Geometry-Selective Preparation of Kilograms of YLF466D, a Potent AMP-Activated Protein Kinase Activator

  • Jianpeng Yin
  • , Desheng Zhan
  • , Hui Ma
  • , Huanan Liu
  • , Lifang Yu
  • , Yangming Zhang*
  • , Fajun Nan*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Abstract

Adenosine 5′-monophosphate-activated protein kinase (AMPK) activator YLF466D is a promising preclinical drug candidate to treat metabolic diseases and myocardial ischemia-reperfusion injury (MIRI). Herein, we report our efforts on optimization and development of a practical and scalable process for the preparation of YLF466D in kilogram scale. The process features a palladium-catalyzed C-H activation under mild reaction conditions, geometry selectivity, effective impurities purging, and low levels of residual solvents in the final active pharmaceutical ingredient (API). We applied this process successfully to prepare more than 17 kg (3.0-3.6 kg per batch) of YLF466D to support its preclinical study.

Original languageEnglish
Pages (from-to)2260-2269
Number of pages10
JournalOrganic Process Research and Development
Volume25
Issue number10
DOIs
StatePublished - 15 Oct 2021
Externally publishedYes

Keywords

  • AMPK activator
  • C-H activation
  • MIRI
  • YLF466D
  • domino reaction
  • glucose metabolism
  • lipid metabolism

Fingerprint

Dive into the research topics of 'Optimization and Development of a Scalable Palladium-Catalyzed C-H Activation Process for the Geometry-Selective Preparation of Kilograms of YLF466D, a Potent AMP-Activated Protein Kinase Activator'. Together they form a unique fingerprint.

Cite this